In this issue
Related Articles
Cited By...
- AD plasma biomarkers are stable for an extended period at -20{degrees}C: implications for resource-constrained environments
- A reusable benchmark of brain-age prediction from M/EEG resting-state signals
- Structural Covariance of the Default Network in Healthy and Pathological Aging
- MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
- Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI
- Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-{beta}1-42 and {tau} Proteins as Alzheimer Disease Biomarkers
- Can MRI screen for CSF biomarkers in neurodegenerative disease?
- Imaging Approaches for Dementia
- White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration
- The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
- Comparing predictors of conversion and decline in mild cognitive impairment